Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.47 CAD | +2.17% | +17.50% | +9.30% |
27/03 | Satellos Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
27/03 | Satellos Bioscience Announces FY 2023 Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.30% | 38.8M | |
+4.78% | 109B | |
+11.78% | 105B | |
+0.73% | 22.25B | |
-11.46% | 22.09B | |
-7.66% | 18.68B | |
-38.36% | 17.58B | |
-9.83% | 16.85B | |
+5.07% | 13.76B | |
+37.37% | 12.46B |
- Stock Market
- Equities
- MSCL Stock
- News Satellos Bioscience Inc.
- Satellos Presented "Positive" Preclinical Efficacy Data for SAT-3247 at the 2024 MDA Clinical & Scientific Conference